Volume 27, Issue 4 - Patient-reported outcomes

The UK pharmaceutical industry braces for Brexit, be it mild, severe, or doomsday

Authors: David Rogers, Ben Rogers, Jacob Lewis, Elsa Lewis

Abstract

Download the full article

References

1. PricewaterhouseCoopers. Brexit: Implications for Pharma and Life Sciences. 2018 [cited 28 August 2018]. Available from: Available from: https://www.pwc.nl/en/brexit/documents/pwc-brexit-monitor-pharma-life-sciences.pdf
2. Charles River Associates. Assessing the impact on the life sciences industry of a change in the UK relationship with the EU. 2016 [cited 28 August 2018] Available from: Available from: https://www.efpia.eu/media/ 25053/assessing-the-impact-on-the-lifesciences- industry-of-a-change-in-the-ukrelationship- with-the-eu-june-2016.pdf.
3. Business Insider UK. House of Lords voted for Theresa May to negotiate a Norwaystyle Brexit. 2018 [cited 04 August 2018]. Available from: Available from: http://uk.businessinsider.com/what-isthe- norway-model-brexit-2018-4.
4. European Medical Agency Brexit plan. 2018. [cited 04 August 2018]. Available from: Available from: http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news_and_.events/ general/general_content_001707.jsp&mid =WC0b01ac0580a809a7.
5. European Commission Directorate- General for Health and Food Safety. Notice to Stakeholders. Withdrawal of the United Kingdom and EU rules in the field of clinical trials. Brussels 06 September 2018. Available from: http://
6. Salako S, Embley P. Brexit: The legal and regulatory impact on supply chain and pharmacovigilance. Regulatory Rapporteur 2018;15(10):4–7. Available from: http://
7. Morris C. Brexit: What would ‘no deal’ mean for food and medicine? BBC News 03 August 2018. [cited 20 Oct ober 2018] Available from: Available from: https://www.bbc.co.uk/ news/uk-45047874.
8. Carr M. Britain Will Probably See Higher Risks of Blackouts After Brexit. Bloomberg 29 January 2018. [cited 16 October 2018] Available from: Available from: https://www.bloomberg.com/news/articles /2018-01-29/brexit-impact-on-energyseen- boosting-risks-of-blackouts-in-u-k.
9. BBC News. Carney: No-deal Brexit risk ‘uncomfortably high’ 03 August 2018. [cited 16 October 2018] Available from: Available from: https://www.bbc.co.uk/news/business- 45055861.
10. House of Commons Business, Energy and Industrial Strategy Committee. The impact of Brexit on the pharmaceutical sector: Ninth Report. 2018. [cited 28 August 2018] Available from: Available from: https://publications.parliament.uk/pa/cm 201719/cmselect/cmbeis/382/382.pdf.
11. HM Government. The Future Relationship between the United Kingdom and the European Union. 2018 [cited 31 August 2018] Available from: Available from: https://www. gov.uk/government/publications/thefuture- relationship-between-the-unitedkingdom- and-the-european-union.
12. Kazzazi F, Pollard C, Tern P, Ayuso-Garcia A, Gillespie J, Thomsen I. Evaluating the impact of Brexit on the pharmaceutical industry. J Pharm Policy Pract. 2017;10(1):32. Available from: http://
13. Parliamentary Office of Science and Technology. Regulating Clinical Trials. Post note number 561, October 2017. [cited 16 October 2018] Available from: Available from: https://researchbriefings.files.parliament. uk/documents/POST-PN-0561/ POST-PN-0561.pdf.
14. Golding B, Waring M. The consequences of ‘Brexit’ for drug discovery and development, and the regulatory implications. Expert Opin Drug Discov. 2018;13(7):583–5. Available from: http://
15. BBC News. AstraZeneca to stockpile drugs for Brexit. 17 July 2018. [cited 28 August 2018]. Available from: Available from: Available from: https://www.bbc. co.uk/news/business-44847914.